175 related articles for article (PubMed ID: 16899063)
41. Anxiolytic-like properties of the anandamide transport inhibitor AM404.
Bortolato M; Campolongo P; Mangieri RA; Scattoni ML; Frau R; Trezza V; La Rana G; Russo R; Calignano A; Gessa GL; Cuomo V; Piomelli D
Neuropsychopharmacology; 2006 Dec; 31(12):2652-9. PubMed ID: 16541083
[TBL] [Abstract][Full Text] [Related]
42. UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide.
de Lago E; Fernández-Ruiz J; Ortega-Gutiérrez S; Viso A; López-Rodríguez ML; Ramos JA
Eur J Pharmacol; 2002 Aug; 449(1-2):99-103. PubMed ID: 12163112
[TBL] [Abstract][Full Text] [Related]
43. AM404, an inhibitor of anandamide reuptake decreases Fos-immunoreactivity in the spinal cord of neuropathic rats after non-noxious stimulation.
Rodella LF; Borsani E; Rezzani R; Ricci F; Buffoli B; Bianchi R
Eur J Pharmacol; 2005 Jan; 508(1-3):139-46. PubMed ID: 15680264
[TBL] [Abstract][Full Text] [Related]
44. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
[TBL] [Abstract][Full Text] [Related]
45. Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.
Vandevoorde S; Jonsson KO; Fowler CJ; Lambert DM
J Med Chem; 2003 Apr; 46(8):1440-8. PubMed ID: 12672243
[TBL] [Abstract][Full Text] [Related]
46. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol.
Spoto B; Fezza F; Parlongo G; Battista N; Sgro' E; Gasperi V; Zoccali C; Maccarrone M
Biochimie; 2006 Dec; 88(12):1889-97. PubMed ID: 16949718
[TBL] [Abstract][Full Text] [Related]
47. Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions.
de Lago E; Ortega-Gutiérrez S; Ramos JA; López Rodríguez ML; Fernández-Ruiz J
Life Sci; 2007 Feb; 80(10):979-88. PubMed ID: 17173937
[TBL] [Abstract][Full Text] [Related]
48. A role for the anandamide membrane transporter in TRPV1-mediated neurosecretion from trigeminal sensory neurons.
Price TJ; Patwardhan AM; Flores CM; Hargreaves KM
Neuropharmacology; 2005 Jul; 49(1):25-39. PubMed ID: 15992578
[TBL] [Abstract][Full Text] [Related]
49. Arachidonylethanolamide induces apoptosis of human glioma cells through vanilloid receptor-1.
Contassot E; Wilmotte R; Tenan M; Belkouch MC; Schnüriger V; de Tribolet N; Burkhardt K; Dietrich PY
J Neuropathol Exp Neurol; 2004 Sep; 63(9):956-63. PubMed ID: 15453094
[TBL] [Abstract][Full Text] [Related]
50. Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study.
Ruiz-Llorente L; Ortega-Gutiérrez S; Viso A; Sánchez MG; Sánchez AM; Fernández C; Ramos JA; Hillard C; Lasunción MA; López-Rodríguez ML; Díaz-Laviada I
Br J Pharmacol; 2004 Feb; 141(3):457-67. PubMed ID: 14718261
[TBL] [Abstract][Full Text] [Related]
51. Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models.
Mitchell VA; Greenwood R; Jayamanne A; Vaughan CW
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1186-90. PubMed ID: 17880375
[TBL] [Abstract][Full Text] [Related]
52. Anandamide: an update.
Smita K; Sushil Kumar V; Premendran JS
Fundam Clin Pharmacol; 2007 Feb; 21(1):1-8. PubMed ID: 17227440
[TBL] [Abstract][Full Text] [Related]
53. Fatty acid amide hydrolase-dependent generation of antinociceptive drug metabolites acting on TRPV1 in the brain.
Barrière DA; Mallet C; Blomgren A; Simonsen C; Daulhac L; Libert F; Chapuy E; Etienne M; Högestätt ED; Zygmunt PM; Eschalier A
PLoS One; 2013; 8(8):e70690. PubMed ID: 23940628
[TBL] [Abstract][Full Text] [Related]
54. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
[TBL] [Abstract][Full Text] [Related]
55. 'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism.
Smart D; Jonsson KO; Vandevoorde S; Lambert DM; Fowler CJ
Br J Pharmacol; 2002 Jun; 136(3):452-8. PubMed ID: 12023948
[TBL] [Abstract][Full Text] [Related]
56. The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats.
Scherma M; Justinová Z; Zanettini C; Panlilio LV; Mascia P; Fadda P; Fratta W; Makriyannis A; Vadivel SK; Gamaleddin I; Le Foll B; Goldberg SR
Br J Pharmacol; 2012 Apr; 165(8):2539-48. PubMed ID: 21557729
[TBL] [Abstract][Full Text] [Related]
57. Evidence for bidirectional endocannabinoid transport across cell membranes.
Chicca A; Marazzi J; Nicolussi S; Gertsch J
J Biol Chem; 2012 Oct; 287(41):34660-82. PubMed ID: 22879589
[TBL] [Abstract][Full Text] [Related]
58. [A new fluorescent analogue for the investigation of anandamide transport in cell cultures].
Gretskaia NM; Akimov MG; Bezuglov VV
Bioorg Khim; 2014; 40(2):248-52. PubMed ID: 25895345
[TBL] [Abstract][Full Text] [Related]
59. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
Bisogno T; Melck D; Bobrov MYu ; Gretskaya NM; Bezuglov VV; De Petrocellis L; Di Marzo V
Biochem J; 2000 Nov; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
[TBL] [Abstract][Full Text] [Related]
60. The cannabinoid system and its pharmacological manipulation--a review, with emphasis upon the uptake and hydrolysis of anandamide.
Fowler CJ
Fundam Clin Pharmacol; 2006 Dec; 20(6):549-62. PubMed ID: 17109648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]